drugset / Trial / NCT00961532
Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept
NaSingle-groupOpen-labelTreatment
Summary
The investigators intend to show that DDAVP improves platelet activity from baseline to 60 minutes after treatment start.
Timeline
- Start
- 2010-12
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desmopressin | Peptide | 0.4 ug/kg | Intravenous |